Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial - Bang, Y J; Van Cutsem, E; Feyereislova, A (Lancet, 2010)
et al.